Enzyme-triggered smart antimicrobial drug release systems against bacterial infections

J Control Release. 2022 Dec:352:507-526. doi: 10.1016/j.jconrel.2022.10.038. Epub 2022 Nov 2.

Abstract

The rapid emergence and spread of drug-resistant bacteria, as one of the most pressing public health threats, are declining our arsenal of available antimicrobial drugs. Advanced antimicrobial drug delivery systems that can achieve precise and controlled release of antimicrobial agents in the microenvironment of bacterial infections will retard the development of antimicrobial resistance. A variety of extracellular enzymes are secreted by bacteria to destroy physical integrity of tissue during their invasion of host body, which can be utilized as stimuli to trigger "on-demand" release of antimicrobials. In the past decade, such bacterial enzyme responsive drug release systems have been intensively studied but few review has been released. Herein, we systematically summarize the recent progress of smart antimicrobial drug delivery systems triggered by bacteria secreted enzymes such as lipase, hyaluronidase, protease and antibiotic degrading enzymes. The perspectives and existing key issues of this field will also be discussed to fuel the innovative research and translational application in the future.

Keywords: Antibiotic resistance; Bacterial enzymes; Bacterial infections; Biofilm formation; Smart drug release systems.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Infective Agents*
  • Bacteria
  • Bacterial Infections* / drug therapy
  • Drug Liberation
  • Humans

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents